Philip J. Mease, MD

Articles by Philip J. Mease, MD

How to Choose Biologic, Oral Therapies in Psoriatic Disease: Philip Mease, MD

February 27th 2026

Philip Mease, MD, shares how to individualize psoriatic disease treatment by weighing medication safety profiles, efficacy, and real-world lifestyle factors.

Experts Highlight the Value of Detailed Clinical Discussions at Maui Derm 2026

ByPearl Steinzor,James Song, MD,Jerry Shapiro, MD,Donna Culton, MD,Philip J. Mease, MD

February 3rd 2026

Experts at Maui Derm 2026 discuss the meeting’s focus on in-depth clinical education, practical patient care pearls, and interdisciplinary networking.

Tailoring Psoriasis, Psoriatic Arthritis Treatment to the Patient: Philip Mease, MD

ByPearl Steinzor,Philip J. Mease, MD

Published: January 28th 2026 | Updated: January 27th 2026

Philip Mease, MD, discusses the different treatment options now available for patients with psoriasis and psoriatic arthritis.

Etanercept: A New Era in the Treatment of Psoriatic Arthritis

ByPhilip J. Mease, MD

April 1st 2002

Latest Updated Articles

Etanercept: A New Era in the Treatment of Psoriatic Arthritis
April 1st 2002

Philip J. Mease, MD

Articles by Philip J. Mease, MD

How to Choose Biologic, Oral Therapies in Psoriatic Disease: Philip Mease, MD

Experts Highlight the Value of Detailed Clinical Discussions at Maui Derm 2026

Tailoring Psoriasis, Psoriatic Arthritis Treatment to the Patient: Philip Mease, MD

Etanercept: A New Era in the Treatment of Psoriatic Arthritis

Latest Updated Articles

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Study Finds Flaw in Method for Key Oncology Value-Based Care Model

Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer